Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-15565 |
Brand: | MCE |
CAS: | 832714-46-2 |
MDL | MFCD12032117 |
---|---|
Molecular Weight | 477.51 |
Molecular Formula | C21H24FN5O5S |
SMILES | O=C(OC(C)C)N(CC1)CCC1OC2=C3C(N(C4=CC=C(S(=O)(C)=O)C=C4F)N=C3)=NC=N2 |
APD668 is a potent, selective and orally active agonist of G-protein coupled receptor GPR119 , with EC 50 s of 2.7 nM and 33 nM for hGPR119 and rGPR119 , respectively. APD668 shows no significant inhibition of any of the five major CYP isoforms with the exception of CYP2C9 ( K i =0.1 μM). APD668 can be used for the research of steatohepatitis and diabetes [1] [2] .
hGPR119 2.7 nM (IC 50 ) |
rGPR119 33 nM (IC 50 ) |
CYP2C9 0.1 μM (Ki) |
hERG channel 3 μM (IC 50 ) |
APD668 increases adenylate cyclase activation in HEK293 cells transfected with human GPR119 in a concentration-dependent manner with an EC
50
of 23 nM
[1]
.
APD668 is highly bound to plasma proteins of male and female cynomolgus monkeys and humans (⩾99%), but is less extensively bound to male (93.0%) and female (96.6%) rats
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
APD668 (10-30 mg/kg; p.o. once daily for 8 weeks) significantly reduces blood glucose and glycated hemoglobin (HbA1c) levels, with no desensitization of the acute drug response
[1]
.
APD668 (1-10 mg/kg; a single p.o.) markedly reduces blood glucose levels during oral glucose tolerance test in a dose-dependent manner in mice
[1]
.
APD668 (0.08 mg/kg/min; i.v.) shows no effect during euglycemic condition, but significantly stimulates insulin release when blood glucose levels are raised to approximately 300 mg/dl in a hyperglycemic clamp model in the Sprague-Dawley rat
[1]
.
APD668 (p.o.) exhibits rapid to moderate absorption (t
max
≤2 h) in mice, rats, and monkeys, but slower in dogs (t
max
=6 h), and moderate to good absolute oral bioavailability (44-79%) in mice, rats, and monkeys, but lower in dogs (22%)
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male Zucker Diabetic Fatty (ZDF) rats (6 weeks old, 200-250 g) [1] |
Dosage: | 10, 30 mg/kg |
Administration: | P.o. once daily for 8 weeks |
Result: |
Decreased the blood glucose and HbA1c levels at 30 mg/kg/day.
Did not develop diabetes, whereas the vehicle treated rats did. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 33.33 mg/mL ( 69.80 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.0942 mL | 10.4710 mL | 20.9420 mL |
5 mM | 0.4188 mL | 2.0942 mL | 4.1884 mL |
10 mM | 0.2094 mL | 1.0471 mL | 2.0942 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.